What is the ticker symbol for BillionToOne?

BillionToOne trades under the ticker BLLN on NASDAQ.

What sector does BillionToOne operate in?

BillionToOne is classified in the Healthcare sector (Medical - Diagnostics & Research industry).

How can PortView help analyze BLLN in a portfolio?

PortView shows BLLN's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.

BillionToOne (BLLN) Stock Analysis

NASDAQHealthcareMedical - Diagnostics & Research

$94.90+2.80%

1-year price historyRange $64.03 – $149.97

52-week range$94.90

$61.96$150.44

What BillionToOne does

BillionToOne, Inc. is a specialized diagnostics company that innovates by precisely quantifying biological data to create advanced molecular diagnostic solutions. Central to their operations is a cutting-edge molecular counting platform, meticulously engineered to identify and measure individual DNA molecules, thereby significantly enhancing the precision of disease detection. Their product portfolio includes: UNITY Complete: A non-invasive prenatal screen that assesses a fetus's risk for aneuploidies, recessive genetic conditions, and fetal antigens, all from a simple maternal blood sample. Northstar Select: A liquid biopsy test designed to pinpoint specific mutations present in tumors, encompassing deletions, insertions, and point mutations. Northstar Response: A diagnostic tool that enables continuous tracking of cancer progression through detailed methylation assessment. Established in 2016, BillionToOne, Inc. conducts its operations from its headquarters located in Menlo Park, California.

Key metrics

Market cap

$4.37B

P/E (TTM)

135.58

EPS (TTM)

$0.70

Beta

0.34

Dividend yield

0.00%

Revenue / share

$8.56

50-day avg

$114.35

200-day avg

$95.13

52-week high

$150.44

52-week low

$61.96

CEO

Oguzhan Atay

ETFs linked to BLLN

Broad-market and Healthcare sector ETFs an investor holding BillionToOne is often also exposed to. Open an ETF page to see its actual top holdings.

SPY — SPDR S&P 500 ETF Trust VOO — Vanguard S&P 500 ETF QQQ — Invesco QQQ Trust VTI — Vanguard Total Stock Market ETF

PortView Portfolio Insights

PortView analyzes how BLLN fits your actual portfolio — position weight, portfolio concentration, unrealized gain/loss, contribution to return, sector exposure, indirect exposure through the ETFs you hold, and correlation with your other holdings. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.

Analyze BLLN in PortView →

Similar companies

JNJ — Johnson &LLY — Eli Lilly A — Agilent Technologies ABBV — AbbVie Inc.ABT — Abbott Laboratories ALNY — Alnylam Pharmaceuticals

Frequently asked questions

What is the ticker symbol for BillionToOne?: BillionToOne trades under the ticker BLLN on NASDAQ.
Which exchange is BLLN listed on?: BLLN is listed on NASDAQ.
What sector does BillionToOne operate in?: BillionToOne is classified in the Healthcare sector (Medical - Diagnostics & Research industry).
How can PortView help analyze BLLN in a portfolio?: PortView shows BLLN's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.

The information provided by PortView is for informational and educational purposes only and does not constitute investment advice. Market data may be delayed. Past performance does not guarantee future results.